Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAB11A, member RAS oncogene family pseudogene 1 (abbreviated as RAB11AP1) is a non-coding genomic DNA segment homologous to the protein-coding RAB11A gene, but it does not produce a functional protein product. Pseudogenes like RAB11AP1 are considered genomic relics and do not have the molecular or functional properties of active therapeutic targets such as receptors, enzymes, or transporters. No current evidence suggests RAB11AP1 is relevant to drug development, disease biology, or biomarker use[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB11A, member RAS oncogene family pseudogene 1 (RAB11AP1).